trial
as of 2026-07-01Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
NCTId NCT00401089
at a glance
Phase 1, Phase 2 · Completed
Enrollment 60 (actual)
Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Primary completion 2006-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1, Phase 2
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2002-12
Primary completion
2006-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sLead Sponsor
Queen's University, BelfastCollaborator
Northern Ontario School of MedicineCollaborator
Imperial College LondonCollaborator
Investigators
1
Simon S Chiu, MD PhDPrincipal Investigator
Sites
4 total
Kingston, CanadaSt. Thomas, CanadaThunder Bay, CanadaHarrow, United Kingdom
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
60
Phase
PHASE1,PHASE2
Primary Completion Date
2006-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person